期刊文献+

乳腺癌组织中巨噬细胞移动抑制因子的表达研究

Expression of macrophage migration inhibitory factor in breast carcinoma tissues
下载PDF
导出
摘要 目的探讨巨噬细胞移动抑制因子(MIF)在乳腺癌组织及癌旁组织中的表达情况。方法运用实时荧光定量PCR及蛋白质印迹分析(Western Blot)方法检测85例乳腺癌组织和相应的癌旁组织中MIF的表达情况。结果乳腺癌组织中MIF mRNA表达量为(3.18±1.19)×10-2,高于癌旁组织的(1.38±0.05)×10-2(P<0.05);Western Blot结果显示乳腺癌组织中MIF蛋白表达水平为(0.879±0.232),高于癌旁组织的(0.325±0.178)(P<0.05)。结论 MIF在乳腺癌组织中表达高于癌旁组织,其可能在乳腺癌发生发展过程中起重要作用。 Objective To explore the expression of macrophage migration inhibitory factor(MIF) in breast carcinoma tissues and para-carcinoma tissues. Methods The MIF expression was detected in 85 cases of breast carcinoma tissues and corresponding para-carcinoma tissues by real-time fluorescent quantitative polymerase chain reaction(FQ-PCR) and Western Blot. Results The expression of MIF mRNA in breast carcinoma tissues was significantly higher than that in para-carcinoma tissues ( (3.18 ± 1.19) × 10^-2 vs. ( 1.38 ±0.05) × 10^-2, P 〈 0. 05). The result of Western Blot showed the expression level of MIF protein in breast carcinoma tissues was significantly higher than that in para-carcinoma tissues (0. 879 ±0. 232 vs. 0. 325 ± 0. 178,P 〈 0. 05 ). Conclusion The MIF expression in breast carcinoma tissues is higher than that in para-careinoma tissues,which indicates that it may play an important role in the process of breast carcinoma development.
出处 《广西医学》 CAS 2015年第3期317-320,共4页 Guangxi Medical Journal
基金 广西自然科学基金(2014GXNSFAA118201)
关键词 乳腺肿瘤 巨噬细胞移动抑制因子 实时荧光定量聚合酶链反应 蛋白质印迹 Breast neoplasm Macrophage migration inhibitory factor Real-time fluorescent quantitative polymerase chain reaction Western Blot
  • 相关文献

参考文献2

二级参考文献26

  • 1Mitchell RA. Mechanisms and effectors of MIF-dependent promotion of tumourigenesis [J]. Cell Signal, 2004,16 ( 1 ) : 13-19.
  • 2Mitchell RA, Liao H, Chesney J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response [J]. Proc Natl Acad Sci USA, 2002,99(1): 345-350.
  • 3Wilson JM, Coletta PL, Cuthbert R J, et al. Macrophage migration inhibitory factor promotes intestinal tumorigenesis[J]. Gastroenterology, 2005,129(5) : 1485 - 1503.
  • 4Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens [J]. Nat Med, 1998,4(7):844-847.
  • 5Beck T, Weikel W, Bmmm C, et al. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC) [J ]. Gynecol Oncol, 1994,53(2) :220-227.
  • 6Hagemann T, Robinson SC, Thompson RG, et al. Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis [J]. Mol Cancer Ther, 2007,6(7) : 1993-2002.
  • 7Takahashi N, Nishihira J, Sato Y, et al. Involvement of macrophage migration inhibitory factor (MIF)in the mechanism of tumor cell growth [ J ]. Mol Med, 1998,4 ( 11 ) : 707-714.
  • 8Liao H, Bucala R, Mitchell RA. Adhesion-dependent signaling by MIF [J]. J Biol Chem, 2003,278(1):76-81.
  • 9Petrenko O, Moll UM. Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway [J]. Mol Cell, 2005, 17(2) : 225-236.
  • 10Sun B, Nishihira J, Yoshiki T, et al. Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-Dependent pathway [J]. Clin Cancer Res, 2005,11 (3) : 1050-1058.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部